Recombinant Involucrin anticorps (full length)

N° du produit ABIN7878462

L’anticorps anti-Involucrin Monoclonal Souris est utilisé pour la détection de Involucrin dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour Recombinant Involucrin anticorps (full length) (ABIN7878462)

Antigène: Involucrin (IVL)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Involucrin est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: RIVRN-9323

Détail du produit anti-Involucrin anticorps

Épitope: full length

Fonction: Recombinant IVL Antibody / Involucrin (azide and preservative free)

Purification: Protein A/G affinity

Immunogène: Recombinant human full-length Involucrin protein was used as the immunogen for the recombinant IVL antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the recombinant IVL antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: -20 °C

Stockage commentaire: Aliquot the recombinant IVL antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur Involucrin

Antigène: Involucrin (IVL)

Autre désignation: IVL

Sujet: It recognizes a protein of 66 kDa-170 kDa, identified as involucrin. In Western blotting of cultured human keratinocytes, this MAb reacts with a 120 kDa protein. It stains the involucrin in a variety of sizes: 170 kDa in MCF-7 cells, a doublet of ~115 kDa and 150 kDa in gorilla and owl monkey, 66 kDa in dog, and a doublet of 105 kDa in pig. Its epitope maps between codon 421-568 of human involucrin. Involucrin is expressed in a range of stratified squamous epithelia, including the cornea, which lacks a distinct cornified layer. In normal epidermis, it is first expressed in the upper spinous layers, and in keratinocyte cultures, all cells that have left the basal layer express it. Involucrin expression is altered in pathological conditions: in psoriasis and other benign epidermal hyperplasias, involucrin expression begins closer to the basal layer than normal, expression is abnormal in squamous cell carcinomas and premalignant lesions, and is reduced in severe dysplasias of the larynx and cervix.

UniProt: P07476